Allergic contact dermatitis (ACD) is a delayed type hypersensitivity reaction that is mediated by hapten-specific T cells. Dinitrochlorobenzene (DNCB)-induced contact hypersensitivity of the skin is a commonly-used mice model for studying the pathogenesis of contact dermatitis. IK cytokine is known to suppress IFN-γ induced expression of MHC class II molecules on B cells by increasing cAMP. Recently, we reported that truncated IK (tIK) cytokine-expressed transgenic (Tg) mouse ameliorated inflammatory arthritis symptoms by suppressing the differentiation of TH1 and TH17 cells and the activation of macrophages. However, there are still limited studies showing the functionality of this cytokine in inflammatory diseases such as ACD. Here, we investigated whether tIK cytokine expressing Tg mice are less susceptible for DNCB induced ACD. DNCB treatment caused severe dermatitis symptoms in wild type (WT) including weight loss, increased ear thickness and scratching behavior but those symptoms are significantly reduced in tIK Tg mice. The weights of draining lymph node (dLN) and spleen were also much less in tIKTg mice. In addition, tIK overexpression decreased IgE serum level, mRNA transcript of mast cell associated factors in Tg mice compared to WT mice. Analyzing T cell subpopulation in dLN revealed that Th2 and Th17 cell differentiation were suppressed by tIK expression while Tregs and Th1 differentiation were not affected. Taken together, our results presented here suggest that tIK expression effectively attenuate DNCB induced allergic contact dermatitis lesions by modulation Th cell differentiation. Futher studies are needed to elucidate immunological and molecular mechanisms by which tIK functions on this disease model.